ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

STX Shield Therapeutics Plc

1.625
0.275 (20.37%)
Last Updated: 13:28:28
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Shield Therapeutics Plc LSE:STX London Ordinary Share GB00BYV81293 ORD 1.5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.275 20.37% 1.625 1.55 1.70 1.625 1.35 1.35 9,979,576 13:28:28
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 4.47M -40.44M -0.0522 -0.30 12.02M
Shield Therapeutics Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker STX. The last closing price for Shield Therapeutics was 1.35p. Over the last year, Shield Therapeutics shares have traded in a share price range of 1.075p to 12.75p.

Shield Therapeutics currently has 775,429,360 shares in issue. The market capitalisation of Shield Therapeutics is £12.02 million. Shield Therapeutics has a price to earnings ratio (PE ratio) of -0.30.

Shield Therapeutics Share Discussion Threads

Showing 22926 to 22946 of 23225 messages
Chat Pages: 929  928  927  926  925  924  923  922  921  920  919  918  Older
DateSubjectAuthorDiscuss
21/2/2024
08:48
This management has a history of doing surprise deeply discounted preemptive placings Sp right now is around 3p they can pull one off and raise 10 million issuing 1billion shares at 1p.
hamidahamida
21/2/2024
08:48
this is overdone.
after all, the company has $4.3m revenue in Q4
though there is a risk
it has already been priced in.

qipincha
21/2/2024
08:44
Result don't look too bad is this overdone or a falling knife
mally6
21/2/2024
08:42
Help. Man the lifeboats. 🤣. Sold mine in feb 2022 for 29p. Been waiting patiently. Should I buy at sub 3p. You better believe it. This share has been good for me. DYOR
jasonpugh
21/2/2024
08:38
Qipincha. They are going to run out of cash very soon and will have to raise well before that happens.
purchaseatthetop
21/2/2024
08:38
Deeply discounted placing coming soon Get out whilst you can
hamidahamida
21/2/2024
08:36
At the time of September placing company said Average cash burn figure was 3.3 million Assuming that burn rate they have already burnt through further 6 million+ What's left at the end of February about 7/8millionDeeply Placing is coming sooner than you think
hamidahamida
21/2/2024
08:31
cash position of $13.9m

revenue last quarter is £4.3, estimated 2024 income is between $17.2 (with no increase) to $22m (with 1.2 quarterly increase)

assuming a $3m monthly spend.

potential income from ex-US, milestone payment, China etc.,

I think the company is fine in 2024 financially. though the spend must be really carefully managed

and we are more realistic with the sale price and volume,

qipincha
21/2/2024
08:28
NY Boy - 07 Aug 2019 - 14:46:09 - 1533 of 4106 Shield Therapeutics - STX
Well I added another lot @ 158p, happy with the share price opportunity

scorpio13
21/2/2024
08:24
well, agree sales volume in q4 is not so good

positive side is the sale price overall increased from $119 in H1 2023 to $145 in H2

qipincha
21/2/2024
08:17
What the hell.How bad is this share :(
neotheone
21/2/2024
08:16
"Your just as bad?"

I've backed the company, been positive through all the dark days of the last 18 months and supported all the ensuing fundraises if you think I'm twisting things here for my own agenda then seriously wtf?!

What's the point..

tripletop1
21/2/2024
08:11
They've over stated both that's why you have prior REPORTED numbers and UPDATED numbers
hatfullofsky
21/2/2024
08:09
Haha! No….not one of mine.
purchaseatthetop
21/2/2024
08:07
Isn't this another one of "patt's picks"..? Seems to be performing as expected..
dplewis1
21/2/2024
08:04
Have sold out at 4p taking a small loss. What a shame / disgrace. Clearly Accrufer has value - in excess of the current share price. But whatever the price goes to today, any funding thereafter will be dilutive and waiting for that will be very painful.
sicilian_kan
21/2/2024
08:03
Im not going to say I told you all !
amaretto1
21/2/2024
08:01
Your as bad as the management as they have income coming in so your twisting so far the wrong way too - your just as bad
little minx
21/2/2024
07:59
They haven’t overstated prescription numbers. They’re overstated their projections. Big difference
ih_361860
21/2/2024
07:53
Little Minx - you do realise what's happened today right?

They have overstated their prescription numbers!!!!

No amount of positive spin and PR is going to save the company now

Who's going to believe anything the company says anymore?

tripletop1
21/2/2024
07:53
But some numpties would still believe this lying management and buy into dangling carrots
hamidahamida
Chat Pages: 929  928  927  926  925  924  923  922  921  920  919  918  Older

Your Recent History

Delayed Upgrade Clock